Tolemy Bio

Tolemy Bio is a biotech startup developing Orbit, an AI-native platform designed to help researchers better understand, interpret, and optimize living cells for modern therapies and drug development. The platform aims to address the fragmentation and manual nature of current experimental workflows by connecting existing lab tools and data sources, incorporating virtual cell models, and utilizing AI research agents for analysis and decision-making. Their long-term goal is to build a virtual-cell platform that enables more precise and data-driven approaches to cell biology research and biopharma development.